We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

134 hedge funds and large institutions have $315M invested in Cytokinetics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 132 → 134 (+2)

7% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 46

2.32% less ownership

Funds ownership: 73.92% → 71.59% (-2.3%)

38% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.99M

45% less capital invested

Capital invested by funds: $575M → $315M (-$261M)

Holders
134
Holders Change
+2
Holders Change %
+1.52%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
43
Reduced
46
Closed
21
Calls
$1.24M
Puts
$1.99M
Net Calls
-$754K
Net Calls Change
-$3.51M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$50.9M
2
WA
Wasatch Advisors
Utah
+$11.1M
3
State Street
State Street
Massachusetts
+$10M
4
BlackRock
BlackRock
New York
+$4.47M
5
TCM
Tekla Capital Management
Massachusetts
+$3.98M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$40.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.7M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.4M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.33M
5
Invesco
Invesco
Georgia
-$7.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
26
Squarepoint
New York
$1.14M +$781K +68,754 +97%
Invesco
27
Invesco
Georgia
$1.11M -$7.56M -666,157 -83%
FIM
28
Freedom Investment Management
Connecticut
$1.11M +$44.8K +3,949 +3%
PAI
29
Palo Alto Investors
California
$1.01M – – –
USAA
30
United Services Automobile Association
Texas
$1.01M +$64.5K +5,681 +5%
AllianceBernstein
31
AllianceBernstein
Tennessee
$955K -$52.2K -4,600 -4%
Two Sigma Investments
32
Two Sigma Investments
New York
$928K +$932K +82,093 +258%
Allianz Asset Management
33
Allianz Asset Management
Germany
$913K -$16K -1,406 -1%
EIM
34
Essex Investment Management
Massachusetts
$878K +$329K +28,970 +37%
IIM
35
Ironwood Investment Management
Massachusetts
$873K -$38.3K -3,373 -3%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$860K +$198K +17,464 +20%
PAM
37
Panagora Asset Management
Massachusetts
$805K +$651K +57,311 +138%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$752K -$607K -53,440 -37%
Legal & General Group
39
Legal & General Group
United Kingdom
$734K +$13.8K +1,220 +1%
JP Morgan Chase
40
JP Morgan Chase
New York
$712K +$992K +87,385 New
ASRS
41
Arizona State Retirement System
Arizona
$694K +$669K +58,934 +225%
Acadian Asset Management
42
Acadian Asset Management
Massachusetts
$687K -$3.58M -314,919 -79%
CAM
43
ClariVest Asset Management
California
$682K -$62.9K -5,542 -6%
New York State Teachers Retirement System (NYSTRS)
44
New York State Teachers Retirement System (NYSTRS)
New York
$676K +$696K +61,300 +284%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$674K – – –
Prudential Financial
46
Prudential Financial
New Jersey
$658K -$9.76K -860 -1%
Ohio Public Employees Retirement System (OPERS)
47
Ohio Public Employees Retirement System (OPERS)
Ohio
$656K +$617K +54,333 +208%
TA
48
Teachers Advisors
New York
$624K +$26.6K +2,344 +3%
Two Sigma Advisers
49
Two Sigma Advisers
New York
$610K +$327K +28,800 +63%
VRS
50
Virginia Retirement Systems
Virginia
$610K +$850K +74,900 New
1
2
3 4 5

CYTK Hedge Fund Activity: Q4 2017 in Review

134 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2017, worth a combined $315M — down 45% from $575M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 21 closed out — a net gain of 3 holders — while 43 added to existing stakes and 46 trimmed.

The largest buyer was BVF Inc, adding an estimated $50.9M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $40.3M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q4 2017, up from 132 in Q3 2017.
  • Funds reported $315M of Cytokinetics stock for Q4 2017, down 45% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q4 2017 and 21 closed out, a net change of +3 holders.
  • The largest Cytokinetics buyer in Q4 2017 was BVF Inc, an estimated $50.9M added.
  • The largest Cytokinetics seller in Q4 2017 was Janus Henderson Group, an estimated $40.3M sold.

Based on aggregated 13F filings for Q4 2017.